Developer docs
API playgroundTry for free, no card

Search company profiles

Applied Biosystems

Full company profile

uuid000akjn

Namestring
Applied Biosystems
Legal namestring
Thermo Fisher Scientific Inc.
Company typeenum
Public
Founded yearint
1987
Descriptiontext

Applied Biosystems is a genetic analysis brand within Thermo Fisher Scientific's Life Sciences Solutions segment, providing instruments, reagents, and software for PCR (qPCR and digital PCR), Sanger sequencing by capillary electrophoresis, microarray analysis, and rapid DNA forensic identification. Its product portfolio centers on the QuantStudio instrument platform, TaqMan real-time PCR assays, custom oligos/primers/probes, GeneArt gene synthesis services, and the RapidHIT ID system for human identification. Core technology spans molecular counting (digital PCR), real-time fluorescence-based qPCR with proprietary assay design algorithms, and trusted capillary electrophoresis sequencing. The brand was founded in 1987 under Perkin-Elmer as a pioneer of commercial PCR, passed through Applera Corporation and Life Technologies, and was acquired by Thermo Fisher Scientific in 2013 as part of the approximately $13.8 billion Life Technologies transaction.

The business model combines instrument sales (QuantStudio Absolute Q, Sanger CE systems, microarray platforms, RapidHIT ID) with high-margin recurring consumables revenue from TaqMan assays, oligos, primers, and probes, plus professional services for instrument qualification, training through Taq Academy, and Unity Lab Services support. Commercial motion is enterprise sales-led, leveraging Thermo Fisher Scientific's global direct sales force, direct eCommerce with Quick Order functionality, B2B eProcurement integration, and a dedicated Supply Center for consumables. Target verticals span research institutions, biopharma, clinical testing laboratories, forensics and law enforcement, reproductive health research, and agricultural biotechnology. Revenue is not separately disclosed and is consolidated under Thermo Fisher Scientific (NYSE: TMO), incorporated in Delaware, USA.

Distribution is global through Thermo Fisher's worldwide service and support infrastructure. The brand positions itself on accuracy, reproducibility, and 40+ years of scientific credibility, with proprietary trademarks (TaqMan, QuantStudio, GeneArt, RapidHIT, Applied Biosystems) reinforcing intangible asset value. Growth drivers include digital PCR adoption in clinical and biopharma workflows, expansion of microarray applications in pharmacogenomics and reproductive health, and recurring consumables pull-through from an expanding installed instrument base.

Short descriptiontext

Applied Biosystems, a brand within Thermo Fisher Scientific's Life Sciences Solutions segment, provides genetic analysis instruments and consumables — qPCR, digital PCR (QuantStudio), Sanger sequencing, microarrays, and rapid DNA forensics — to research, biopharma, clinical, forensic, and agricultural customers globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersFoster City, United States
HQ citystring
Foster City
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
genetic analysis instruments, real-time PCR assays, digital PCR systems, Sanger sequencing platforms, microarray analysis solutions
Industry4 codes
1Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
CodeHLAGAIAFPrimaryYes
2Molecular Diagnostics (PCR/qPCR, NGS-based assays)
CodeHLAAALAAPrimaryNo
3Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
CodeHLAAALADPrimaryNo
4Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)
CodeHLAAALALPrimaryNo
NAICS code3 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Medical Laboratories621511
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Laboratory Analytical Instruments3826
  • Services-Commercial Physical & Biological Research8731
Product category
Genetic Analysis Instruments and Reagents
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Genetic Analysis Instruments and Consumables
TypeHardware Sales
Description

Sale of genetic analysis instruments including real-time PCR systems, digital PCR systems, Sanger sequencing systems, and microarray platforms along with associated consumables such as TaqMan assays, oligos, primers, and probes

thermofisher.com
2Instrument Services and Support
TypeProfessional Services
Description

Technical service and support solutions for Applied Biosystems instruments backed by over 40 years of service expertise, including instrument qualification services and Unity Lab Services

thermofisher.com
3Training and Learning Services
TypeProfessional Services
Description

Educational services including Taq Academy for qPCR and dPCR technology training, learning centers, and technical training resources

thermofisher.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1TaqMan
Description

TaqMan Real-Time PCR Assays - gold standard real-time PCR chemistry for gene expression, SNP genotyping, and copy number variation analysis

thermofisher.com
+3 more records
Core offering1 text field

Applied Biosystems manufactures and sells genetic analysis instruments and consumables spanning real-time PCR (qPCR), digital PCR (dPCR), Sanger sequencing by capillary electrophoresis, microarray analysis, and rapid DNA identification systems. The portfolio also includes TaqMan real-time PCR assays, custom oligos/primers/probes, and GeneArt gene synthesis, delivered with accompanying data analysis software, training, and instrument services to research, biopharma, clinical, forensic, and agricultural biotechnology customers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Highly precise and sensitive results for molecular counting applications
+2 more records
Product overview1 text field

Applied Biosystems, a brand of Thermo Fisher Scientific, provides an extensive portfolio of genetic analysis solutions including real-time PCR (qPCR) with TaqMan assays, digital PCR systems (QuantStudio Absolute Q), Sanger sequencing by capillary electrophoresis, microarray analysis, and Rapid DNA forensic solutions. The platform offers a complete end-to-end workflow from foundational qPCR and microarray technologies to cutting-edge digital PCR innovations, serving research, biopharma, clinical testing, forensics, reproductive health, and agribusiness applications.

Product and service9 records
1QuantStudio Absolute Q Digital PCR System
CategoryDigital PCR Instruments
Description

Digital PCR instrument platform that uses molecular counting to deliver highly precise and sensitive results, supporting absolute quantification of differential gene expression and rare-allele detection for research and clinical customers.

2TaqMan Real-Time PCR Assays
CategoryPCR Reagents and Assays
Description

Real-time PCR assays and reagent chemistry providing accurate, highly reproducible results for gene expression, SNP genotyping, copy number variation, and other genetic testing and research applications.

3Oligos, Primers, Probes and Genes
CategoryCustom Nucleic Acid Reagents
Description

Custom-synthesized oligonucleotides, primers, probes, and gene products supplied to molecular biology researchers and assay developers for PCR, sequencing, and related workflows.

4GeneArt Gene Synthesis
CategoryGene Synthesis Services
Description

Custom DNA gene synthesis service producing designed sequences for research, cloning, protein expression, and biopharmaceutical development applications.

5Sanger Sequencing Systems
CategorySanger Sequencing Instruments
Description

Genetic analysis systems for Sanger sequencing and fragment analysis by capillary electrophoresis, used as a trusted standard across research and clinical workflows.

6Microarray Analysis Solutions
CategoryMicroarray Platforms
Description

Microarray platforms, tools, and arrays (including Axiom PharmacoPro and PangenomePro products) for cytogenetics, reproductive health research, and genotyping applications.

7Rapid DNA Solutions (RapidHIT ID System)
CategoryForensic DNA Instruments
Description

Rapid DNA analysis system providing streamlined end-to-end forensic DNA workflows for human identification, criminal investigation, missing persons, and database-ready sample processing.

8Taq Academy Training and Learning Services
CategoryTraining and Educational Services
Description

Educational and certification services for qPCR and dPCR technologies, delivered through Taq Academy learning centers and training resources.

9Instrument Services and Support
CategoryInstrument Services and Support
Description

Technical service, qualification, maintenance, and support offerings for Applied Biosystems instruments, provided globally through Thermo Fisher Scientific's service organization.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Bio-Rad is a direct competitor across qPCR, digital PCR (QX200 ddPCR), and clinical diagnostics, with overlapping product lines in life science research instruments and consumables. The ddPCR platform is Applied Biosystems' most direct head-to-head competitor to QuantStudio Absolute Q.

TypeDirect peer
Description

QIAGEN competes directly in molecular biology sample preparation, PCR reagents, and molecular diagnostics workflows. Their QIAcuity digital PCR system is a direct QuantStudio competitor, and their broader PCR/assay portfolio overlaps with Applied Biosystems' TaqMan franchise.

TypeBroad incumbent
Description

Roche operates the LightCycler qPCR platform and a broad molecular diagnostics portfolio that competes with Applied Biosystems in clinical qPCR. As a large diversified incumbent, Roche offers overlapping capabilities across the genetic analysis workflow from sample to result.

TypeDirect peer
Description

Illumina is the dominant next-generation sequencing platform provider and competes with Applied Biosystems across sequencing workflows. While Illumina focuses on NGS vs. Applied Biosystems' Sanger strength, both companies serve genetic analysis markets in research, clinical, and applied segments.

TypeBroad incumbent
Description

Agilent manufactures analytical laboratory instruments, genomics reagents (including SureSelect), and microarray platforms that overlap with Applied Biosystems' microarray and analytical instrument offerings. Both serve research and clinical molecular biology customers.

TypeBroad incumbent
Description

BD operates in molecular diagnostics through BD MAX and BD FACSDiscover, with overlapping clinical qPCR and flow cytometry applications. The molecular diagnostics franchise competes with Applied Biosystems' clinical testing lab offerings.

TypeDirect peer
Description

Promega provides molecular biology reagents, PCR enzymes, and genetic analysis tools that compete with Applied Biosystems' TaqMan and GeneArt franchises. Both companies focus on life science research consumables and custom oligonucleotide/gene synthesis services.

TypeBroad incumbent
Description

Danaher's Beckman Coulter and Cepheid subsidiaries offer molecular diagnostics and laboratory automation that overlap with Applied Biosystems' clinical testing segment. As a diversified life sciences conglomerate, Danaher competes across multiple Applied Biosystems end markets.

TypeBroad incumbent
Description

PerkinElmer is the original parent of Applied Biosystems (founded 1987 as part of Perkin-Elmer) and now operates in life sciences, diagnostics, and analytical instruments. Direct overlap in genetic analysis, newborn screening, and applied genomics markets.

TypeBroad incumbent
Description

Following the 2023 separation of PerkinElmer's food/environmental businesses, Revvity carries forward the life sciences and diagnostics portfolio including reagents, software, and applied genomics offerings that overlap with Applied Biosystems' research and clinical segments.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile6 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Applied Biosystems

Genetic Analysis Instruments and Reagentsappliedbiosystems.com

Applied Biosystems, a brand within Thermo Fisher Scientific's Life Sciences Solutions segment, provides genetic analysis instruments and consumables — qPCR, digital PCR (QuantStudio), Sanger sequencing, microarrays, and rapid DNA forensics — to research, biopharma, clinical, forensic, and agricultural customers globally.

What Applied Biosystems does

Applied Biosystems is a genetic analysis brand within Thermo Fisher Scientific's Life Sciences Solutions segment, providing instruments, reagents, and software for PCR (qPCR and digital PCR), Sanger sequencing by capillary electrophoresis, microarray analysis, and rapid DNA forensic identification. Its product portfolio centers on the QuantStudio instrument platform, TaqMan real-time PCR assays, custom oligos/primers/probes, GeneArt gene synthesis services, and the RapidHIT ID system for human identification. Core technology spans molecular counting (digital PCR), real-time fluorescence-based qPCR with proprietary assay design algorithms, and trusted capillary electrophoresis sequencing. The brand was founded in 1987 under Perkin-Elmer as a pioneer of commercial PCR, passed through Applera Corporation and Life Technologies, and was acquired by Thermo Fisher Scientific in 2013 as part of the approximately $13.8 billion Life Technologies transaction.

The business model combines instrument sales (QuantStudio Absolute Q, Sanger CE systems, microarray platforms, RapidHIT ID) with high-margin recurring consumables revenue from TaqMan assays, oligos, primers, and probes, plus professional services for instrument qualification, training through Taq Academy, and Unity Lab Services support. Commercial motion is enterprise sales-led, leveraging Thermo Fisher Scientific's global direct sales force, direct eCommerce with Quick Order functionality, B2B eProcurement integration, and a dedicated Supply Center for consumables. Target verticals span research institutions, biopharma, clinical testing laboratories, forensics and law enforcement, reproductive health research, and agricultural biotechnology. Revenue is not separately disclosed and is consolidated under Thermo Fisher Scientific (NYSE: TMO), incorporated in Delaware, USA.

Distribution is global through Thermo Fisher's worldwide service and support infrastructure. The brand positions itself on accuracy, reproducibility, and 40+ years of scientific credibility, with proprietary trademarks (TaqMan, QuantStudio, GeneArt, RapidHIT, Applied Biosystems) reinforcing intangible asset value. Growth drivers include digital PCR adoption in clinical and biopharma workflows, expansion of microarray applications in pharmacogenomics and reproductive health, and recurring consumables pull-through from an expanding installed instrument base.

Applied Biosystems firmographics

Firmographics
Name
Applied Biosystems
Legal name
Thermo Fisher Scientific Inc.
Website
https://appliedbiosystems.com
Company type
Public
Founded year
1987
Operating status
Operating
Headcount range
1–10 employees
Short description
Applied Biosystems, a brand within Thermo Fisher Scientific's Life Sciences Solutions segment, provides genetic analysis instruments and consumables — qPCR, digital PCR (QuantStudio), Sanger sequencing, microarrays, and rapid DNA forensics — to research, biopharma, clinical, forensic, and agricultural customers globally.
Ownership category
akta.pro rank

Applied Biosystems industry classification

Industry
Product category
Genetic Analysis Instruments and Reagents
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Laboratory Analytical Instruments (3826), Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)
akta.pro secondary industries
Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA), Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL)

Keywords

  • Genetic analysis instruments
  • Real-time PCR assays
  • Digital PCR systems
  • Sanger sequencing platforms
  • Microarray analysis solutions

Where Applied Biosystems is headquartered

Location

Headquarters

HQ city
Foster City
HQ country
United States
HQ region
North America

Markets served

Applied Biosystems business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Genetic Analysis Instruments and Consumables: Sale of genetic analysis instruments including real-time PCR systems, digital PCR systems, Sanger sequencing systems, and microarray platforms along with associated consumables such as TaqMan assays, oligos, primers, and probes
  2. Instrument Services and Support: Technical service and support solutions for Applied Biosystems instruments backed by over 40 years of service expertise, including instrument qualification services and Unity Lab Services
  3. Training and Learning Services: Educational services including Taq Academy for qPCR and dPCR technology training, learning centers, and technical training resources

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Applied Biosystems product offering

Product offering

Core offering

Applied Biosystems manufactures and sells genetic analysis instruments and consumables spanning real-time PCR (qPCR), digital PCR (dPCR), Sanger sequencing by capillary electrophoresis, microarray analysis, and rapid DNA identification systems. The portfolio also includes TaqMan real-time PCR assays, custom oligos/primers/probes, and GeneArt gene synthesis, delivered with accompanying data analysis software, training, and instrument services to research, biopharma, clinical, forensic, and agricultural biotechnology customers.

Product overview

Applied Biosystems, a brand of Thermo Fisher Scientific, provides an extensive portfolio of genetic analysis solutions including real-time PCR (qPCR) with TaqMan assays, digital PCR systems (QuantStudio Absolute Q), Sanger sequencing by capillary electrophoresis, microarray analysis, and Rapid DNA forensic solutions. The platform offers a complete end-to-end workflow from foundational qPCR and microarray technologies to cutting-edge digital PCR innovations, serving research, biopharma, clinical testing, forensics, reproductive health, and agribusiness applications.

Differentiator

Problem solved

Functional benefit

Brands

  • TaqMan: TaqMan Real-Time PCR Assays - gold standard real-time PCR chemistry for gene expression, SNP genotyping, and copy number variation analysis
  • QuantStudio
  • GeneArt
  • RapidHIT

Products and services

  • QuantStudio Absolute Q Digital PCR System Digital PCR instrument platform that uses molecular counting to deliver highly precise and sensitive results, supporting absolute quantification of differential gene expression and rare-allele detection for research and clinical customers.
  • TaqMan Real-Time PCR Assays Real-time PCR assays and reagent chemistry providing accurate, highly reproducible results for gene expression, SNP genotyping, copy number variation, and other genetic testing and research applications.
  • Oligos, Primers, Probes and Genes Custom-synthesized oligonucleotides, primers, probes, and gene products supplied to molecular biology researchers and assay developers for PCR, sequencing, and related workflows.
  • GeneArt Gene Synthesis Custom DNA gene synthesis service producing designed sequences for research, cloning, protein expression, and biopharmaceutical development applications.
  • Sanger Sequencing Systems Genetic analysis systems for Sanger sequencing and fragment analysis by capillary electrophoresis, used as a trusted standard across research and clinical workflows.
  • Microarray Analysis Solutions Microarray platforms, tools, and arrays (including Axiom PharmacoPro and PangenomePro products) for cytogenetics, reproductive health research, and genotyping applications.
  • Rapid DNA Solutions (RapidHIT ID System) Rapid DNA analysis system providing streamlined end-to-end forensic DNA workflows for human identification, criminal investigation, missing persons, and database-ready sample processing.
  • Taq Academy Training and Learning Services Educational and certification services for qPCR and dPCR technologies, delivered through Taq Academy learning centers and training resources.
  • Instrument Services and Support Technical service, qualification, maintenance, and support offerings for Applied Biosystems instruments, provided globally through Thermo Fisher Scientific's service organization.

Quantifiable outcome

  • Highly precise and sensitive results for molecular counting applications
  • +2 more outcomes

Companies that use Applied Biosystems

Customer profile

Segments6 records

Ideal customer profiles6 records

Applied Biosystems technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Applied Biosystems partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Applied Biosystems competitors and assessment

Company assessment

Direct peers

  • Bio-Rad Laboratories: Bio-Rad is a direct competitor across qPCR, digital PCR (QX200 ddPCR), and clinical diagnostics, with overlapping product lines in life science research instruments and consumables. The ddPCR platform is Applied Biosystems' most direct head-to-head competitor to QuantStudio Absolute Q.
  • QIAGEN: QIAGEN competes directly in molecular biology sample preparation, PCR reagents, and molecular diagnostics workflows. Their QIAcuity digital PCR system is a direct QuantStudio competitor, and their broader PCR/assay portfolio overlaps with Applied Biosystems' TaqMan franchise.
  • Illumina: Illumina is the dominant next-generation sequencing platform provider and competes with Applied Biosystems across sequencing workflows. While Illumina focuses on NGS vs. Applied Biosystems' Sanger strength, both companies serve genetic analysis markets in research, clinical, and applied segments.
  • Promega Corporation: Promega provides molecular biology reagents, PCR enzymes, and genetic analysis tools that compete with Applied Biosystems' TaqMan and GeneArt franchises. Both companies focus on life science research consumables and custom oligonucleotide/gene synthesis services.

Broad incumbents

  • Roche Diagnostics: Roche operates the LightCycler qPCR platform and a broad molecular diagnostics portfolio that competes with Applied Biosystems in clinical qPCR. As a large diversified incumbent, Roche offers overlapping capabilities across the genetic analysis workflow from sample to result.
  • Agilent Technologies: Agilent manufactures analytical laboratory instruments, genomics reagents (including SureSelect), and microarray platforms that overlap with Applied Biosystems' microarray and analytical instrument offerings. Both serve research and clinical molecular biology customers.
  • Becton Dickinson (BD): BD operates in molecular diagnostics through BD MAX and BD FACSDiscover, with overlapping clinical qPCR and flow cytometry applications. The molecular diagnostics franchise competes with Applied Biosystems' clinical testing lab offerings.
  • Danaher (Beckman Coulter, Cepheid): Danaher's Beckman Coulter and Cepheid subsidiaries offer molecular diagnostics and laboratory automation that overlap with Applied Biosystems' clinical testing segment. As a diversified life sciences conglomerate, Danaher competes across multiple Applied Biosystems end markets.
  • PerkinElmer: PerkinElmer is the original parent of Applied Biosystems (founded 1987 as part of Perkin-Elmer) and now operates in life sciences, diagnostics, and analytical instruments. Direct overlap in genetic analysis, newborn screening, and applied genomics markets.
  • Revvity (formerly PerkinElmer): Following the 2023 separation of PerkinElmer's food/environmental businesses, Revvity carries forward the life sciences and diagnostics portfolio including reagents, software, and applied genomics offerings that overlap with Applied Biosystems' research and clinical segments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Applied Biosystems social profiles

Digital presence

Applied Biosystems financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Applied Biosystems leadership team

Management profile

Number of profiles

Profiles1 record

Applied Biosystems funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Applied Biosystems M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Applied Biosystems

What does Applied Biosystems do?

Applied Biosystems manufactures and sells genetic analysis instruments and consumables spanning real-time PCR (qPCR), digital PCR (dPCR), Sanger sequencing by capillary electrophoresis, microarray analysis, and rapid DNA identification systems. The portfolio also includes TaqMan real-time PCR assays, custom oligos/primers/probes, and GeneArt gene synthesis, delivered with accompanying data analysis software, training, and instrument services to research, biopharma, clinical, forensic, and agricultural biotechnology customers.

Is Applied Biosystems a public or private company?

Applied Biosystems is a public company. It is classified as public and is currently operating.

When was Applied Biosystems founded?

Applied Biosystems was founded in 1987. It employs 1 to 10 people.

Where is Applied Biosystems based?

Applied Biosystems is headquartered in Foster City, United States, in the North America region.

How does Applied Biosystems make money?

Three revenue lines are on record. Genetic Analysis Instruments and Consumables are the primary driver. The others are instrument Services and Support and training and Learning Services.

Who are Applied Biosystems's main competitors?

Direct peers on record are Bio-Rad Laboratories, QIAGEN, Illumina and Promega Corporation. Broad incumbents are Roche Diagnostics, Agilent Technologies, Becton Dickinson (BD), Danaher (Beckman Coulter, Cepheid), PerkinElmer and Revvity (formerly PerkinElmer).

Does Applied Biosystems have an API?

No public API is recorded for Applied Biosystems.

What industry is Applied Biosystems in?

Applied Biosystems's product category is Genetic Analysis Instruments and Reagents. Its primary akta.pro industry code is HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays), with a secondary code of HLAAALAA, Molecular Diagnostics (PCR/qPCR, NGS-based assays). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireNew Thermo Scientific SureTect PCR Assays for expanded foodborne pathogen analysisThermo Fisher Scientific released five new Thermo Scientific SureTect PCR Assays and enhanced software to detect specific foodborne pathogens including Campylobacter, E. coli O157:H7, Staphylococcus aureus, and Vibrio species. These assays integrate with the Applied Biosystems QuantStudio 5 Food Safety PCR System, allowing manufacturers to obtain negative and presumptive-positive results in fewer than 24 hours.PR NewswireFranek Technologies Announces Certified Category III-3 Instrumentation Grade Laboratory Protection Systems for the Applied Biosystems 3500XL Genetic Analyzer and ControllerFranek Technologies has developed a certified, plug-and-play uninterruptible power supply (UPS) and laboratory protection system specifically for the Applied Biosystems 3500XL Genetic Analyzer and Controller. This solution addresses common power issues such as outages, spikes, and voltage fluctuations to protect sensitive laboratory instrumentation. The product is designed to simplify installation by providing pre-configured voltages and receptacles tailored to the instrument's requirements.PR NewswireFranek Technologies announces Certified Category III-3 Instrumentation Grade Laboratory Protection Systems for the Applied Biosystems Prism® 7500 Real­Time PCR Sequence Detector with ControllerFranek Technologies announced the release of a Certified Category III-3 Instrumentation Grade Laboratory Protection System, configured as an uninterruptible power supply unit specifically designed to support the Applied Biosystems Prism 7500 Real-Time PCR Sequence Detector. The UPS/LPS product addresses common power issues faced by laboratories including voltage sags, surges, brownouts, power spikes, and complete power failures. The company states it has support from leading instrument manufacturers including Life Technologies (Applied Biosystems), Agilent, Bio-Rad, Thermo Fisher, and others, and has provided power protection solutions to government agencies including the CDC, FDA, NIH, and USDA.News-MedicalCourtagen announces acquisition of Medicinal GenomicsCourtagen Life Sciences announced the acquisition of Medicinal Genomics Corporation, integrating its operations in Marblehead, Massachusetts, and Amsterdam, Netherlands. This transaction reunites the McKernan brothers, who previously co-founded Agencourt Bioscience and Applied Biosystems, to apply next-generation sequencing technologies to cannabis genomics. The financial terms of the deal were not disclosed.The New York TimesInvitrogen to Buy Applied Biosystems for $6.7 BillionInvitrogen agreed to acquire Applied Biosystems for $6.7 billion in cash and stock, announced Thursday. The deal would create a combined company with about $3.5 billion in annual sales. Applied Biosystems shareholders would receive $38 per share, a 17% premium to the closing price.GlobeNewswireA DNA Data Deluge Confronts ResearchersBio-IT World's April 2008 cover story describes how next-generation DNA sequencers are generating terabytes of data, prompting researchers to abandon traditional storage methods. The first HeliScope sequencer includes 24 terabytes of storage for only two full runs, and the Broad Institute is replacing Applied Biosystems sequencers with 20 Illumina instruments producing 20 billion bases weekly.